The new High Precision Streptavidin 2.0 (SAX2) biosensor for the Octet® platform has recently been launched by ForteBio, the Biologics Business Unit of Molecular Devices. The announcement was made at the Bioprocessing Summit in Boston.
Aiming to fulfill its customers’ requirements to lessen variability from consumables, the SAX2 biosensors are regulated to match the most rigorous of assay precision requirements with less than 4% CV within lots and less than 20% between lots.
Streptavidin biosensors are used for fast and easy customization of biosensors to carry out kinetic and quantitative measurements with any biotin-tagged molecule. By applying a greater level of accuracy with SAX2, this versatile capture technique can be more easily created and qualified in downstream and regulated applications, such as activity assays in manufacturing, product release testing, and others.
The SAX2 biosensor rounds out our product and service offerings to our GxP customers, giving them fast and reliable tools from qualifying instruments to validating methods and maintaining data integrity.
Laurent Claisse, General Manager, ForteBio